Label-free plasmonic metasensing of PSA and exosomes in serum for rapid high-sensitivity diagnosis of early prostate cancer
Biosensors and Bioelectronics · 2023-09 · 235 · 115380
DOI: 10.1016/j.bios.2023.115380 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2023-09. Verfasst von Haotian Liang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Electromagnetics and Acoustics and Key Laboratory of Electromagnetic Wave Science and Detection Technology, Xiamen University, Xiamen, 3…. Hauptthemen laut MEDLINE: Exosomes, Biosensing Techniques, Prostatic Neoplasms, Prostatic Hyperplasia. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Prostate-specific antigen (PSA) test is widely used to diagnose early prostate cancer (PCa). Its low sensitivity, especially in the gray zone, usually incurs overtreatment or missed diagnosis. As an emerging tumor marker, exosomes have attracted great interest in non-invasive diagnosis of PCa. However, the quick direct detection of exosomes in serum is still a big challenge for convenient screening of early PCa due to their high-degree heterogeneity and complexity. Here we develop the label-free biosensors based on wafer-scale plasmonic metasurfaces, and establish a flexible spectral methodology of exosomes profiling, which facilitates their identification and quantification in serum. We combine the metasurfaces functionalized by anti-PSA and anti-CD63, respectively, and build a portable immunoassay system to detect serum PSA and exosomes simultaneously within 20 min. Our scheme can discriminate early PCa from benign prostatic hyperplasia with a diagnostic sensitivity of 92.3%, which is much higher that of 58.3% for conventional PSA tests. The receiver operating characteristic analysis in clinical trials demonstrates significant PCa distinguishing capability with an area under the curve up to 99.4%. Our work provides a rapid and powerful approach for precise diagnosis of early PCa, and will inspire more exosomes metasensing studies for other early cancer screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Electromagnetics and Acoustics and Key Laboratory of Electromagnetic Wave Science and Detection Technology, Xiamen University, Xiamen, 361005, China.
- Department of Urology, The First Affiliated Hospital of Xiamen University, Xiamen 361003, China.
- Analysis and Measurement Center, School of Pharmaceutical Science, Xiamen University, Xiamen, 361003, China.
- Institute of Electromagnetics and Acoustics and Key Laboratory of Electromagnetic Wave Science and Detection Technology, Xiamen University, Xiamen, 361005, China. Electronic address: nanoantenna@hotmail.com.
Zitieren
APA
Liang, H., Wang, X., Li, F., Xie, Y., Shen, J., Wang, X., Huang, Y., Lin, S., Chen, J., Zhang, L., Jiang, B., Xing, J., & Zhu, J. (2023). Label-free plasmonic metasensing of PSA and exosomes in serum for rapid high-sensitivity diagnosis of early prostate cancer. Biosensors and Bioelectronics, 235, 115380. https://doi.org/10.1016/j.bios.2023.115380
Vancouver
Liang H, Wang X, Li F, Xie Y, Shen J, Wang X, et al. Label-free plasmonic metasensing of PSA and exosomes in serum for rapid high-sensitivity diagnosis of early prostate cancer. Biosensors and Bioelectronics. 2023;235:115380. doi:10.1016/j.bios.2023.115380
BibTeX
@article{Liang2023,
author = {Liang, Haotian and Wang, Xuegang and Li, Fajun and Xie, Yinong and Shen, Jiaqing and Wang, Xueqin and Huang, Yuqian and Lin, Shaowei and Chen, Junjie and Zhang, Lijian and Jiang, Bingliang and Xing, Jinchun and Zhu, Jinfeng},
title = {Label-free plasmonic metasensing of PSA and exosomes in serum for rapid high-sensitivity diagnosis of early prostate cancer},
journal = {Biosensors and Bioelectronics},
year = {2023},
volume = {235},
pages = {115380},
doi = {10.1016/j.bios.2023.115380}
}
EUVIMED